View Older Stories
-
BioHarvest launches chewable version of its VINIA supplement
-
BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
-
BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
BioHarvest Sciences seeks dual listing on Tel Aviv Stock Exchange
-
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
-
Q3 Virtual Investor Summit Presentations Now Available On Demand
-
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss of $0.17
-
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
-
BioHarvest signs 20-ton fragrance supply deal worth up to $30M
-
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
-
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
-
BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
-
BioHarvest receives $1.4M grant from Israel Innovation Authority
-
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
-
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
-
Q2 Investor Summit Virtual Live Wednesday June 24
-
Q2 Investor Summit Virtual Live Wednesday June 24
-
BioHarvest Sciences to Present at the 2026 BIO International Convention
-
Tate & Lyle expands sweetener collaboration with BioHarvest Sciences
-
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
-
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
-
BioHarvest Sciences names Nedira Salzman-Frenkel business development VP
-
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
-
BioHarvest Sciences completes stage 1 saffron development program
-
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
-
BioHarvest Sciences secures $1.2M contract for rare fragrance development
-
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
-
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
-
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
-
H.C. Wainwright Reiterates Buy Rating on BioHarvest Sciences (BHST)
-
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
-
BioHarvest Sciences develops stable cell culture for rare fragrance plant
-
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
-
BioHarvest says VINIA becomes top US resveratrol supplement brand
-
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
-
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
-
BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors
-
BioHarvest Sciences appoints Prof. Hezi Levy to board
-
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
-
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
-
Barclays Downgrades BASF SE (BAS:GR) (BASFY) to Underweight
-
Roth/MKM Starts BioHarvest Sciences (BHST) at Buy
-
BioHarvest Sciences Issues Year End Shareholder Letter
-
BioHarvest Sciences receives $1.6 million grant from Israeli authority
-
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
-
BioHarvest Sciences launches VINIA blood flow hydration product
-
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
-
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
-
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025
-
BioHarvest Sciences closes $19.9 million public offering


